Vinay Prasad on Pharmaceuticals, the FDA, and the Death of Duty
[ANNUAL LISTENER SURVEY: https://www.surveymonkey.com/r/EconTalk2022Fav. Vote for your 2022 favorites!] Oncologist and epidemiologist Vinay Prasad argues that too many very expensive drugs get approved by the FDA that have very limited impact on the lives of patients. Prasad explains the incentives that distort the current system. The general problem, he explains to EconTalk host Russ Roberts, […] The post Vinay Prasad on Pharmaceuticals, the FDA, and the Death of Duty appeared first on Econlib.